This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seales, E. C. Articles by Bellis, S. L. Search for Related Content PubMed PubMed Citation Articles by Seales, E. C. Articles by Bellis, S. L.

Hypersialylation of ß₁ Integrins, Observed in Colon Adenocarcinoma, May Contribute to Cancer Progression by Up-regulating Cell Motility

Departments of ¹ Pathology and ² Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama and ³ Tranzyme, Inc., Research Triangle Park, North Carolina

Requests for reprints: Susan L. Bellis, Department of Physiology and Biophysics, Room 982A MCLM, 1918 University Boulevard, Birmingham, AL 35294. Phone: 205-934-3441; Fax: 205-975-9028; E-mail: bellis{at}physiology.uab.edu.

Colon adenocarcinomas are known to express elevated levels of 2-6 sialylation and increased activity of ST6Gal-I, the Golgi glycosyltransferase that creates 2-6 linkages. Elevated ST6Gal-I positively correlates with metastasis and poor survival, and therefore ST6Gal-I–mediated hypersialylation likely plays a role in colorectal tumor invasion. Previously we found that oncogenic ras (present in roughly 50% of colon adenocarcinomas) up-regulates ST6Gal-I and, in turn, increases sialylation of ß₁ integrin adhesion receptors in colon epithelial cells. However, we wanted to know if this pattern held true in vivo and, if so, how ß₁ hypersialylation might contribute to colon tumor progression. In the present study, we find that ß₁ integrins from colon adenocarcinomas consistently carry higher levels of 2-6 sialic acid. To explore the effects of increased 2-6 sialylation on ß₁-integrin function, we stably expressed ST6Gal-I in a colon epithelial cell line lacking endogenous ST6Gal-I. ST6Gal-I expressors (with 2-6 sialylated ß₁ integrins) exhibited up-regulated attachment to collagen I and laminin and increased haptotactic migration toward collagen I, relative to parental cells (with completely unsialylated ß₁ integrins). Blockade of ST6Gal-I expression with short interfering RNA reversed collagen binding back to the level of ST6Gal-I nonexpressors, confirming that 2-6 sialylation regulates ß₁ integrin function. Finally, we show that ß₁ integrins from ST6Gal-I expressors have increased association with talin, a marker for integrin activation. Collectively, these findings suggest that ß₁ hypersialylation may augment colon tumor progression by altering cell preference for certain extracellular matrix milieus, as well as by stimulating cell migration.

This article has been cited by other articles:

				A. V. Woodard-Grice, A. C. McBrayer, J. K. Wakefield, Y. Zhuo, and S. L. Bellis Proteolytic Shedding of ST6Gal-I by BACE1 Regulates the Glycosylation and Function of {alpha}4{beta}1 Integrins J. Biol. Chem., September 26, 2008; 283(39): 26364 - 26373. [Abstract] [Full Text] [PDF]

				Y. Zhuo, R. Chammas, and S. L. Bellis Sialylation of {beta}1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced Apoptosis J. Biol. Chem., August 8, 2008; 283(32): 22177 - 22185. [Abstract] [Full Text] [PDF]

				M. Lee, H.-J. Lee, S. Bae, and Y.-S. Lee Protein Sialylation by Sialyltransferase Involves Radiation Resistance Mol. Cancer Res., August 1, 2008; 6(8): 1316 - 1325. [Abstract] [Full Text] [PDF]

				M. Hedlund, E. Ng, A. Varki, and N. M. Varki {alpha}2-6 Linked Sialic Acids on N-Glycans Modulate Carcinoma Differentiation In vivo Cancer Res., January 15, 2008; 68(2): 388 - 394. [Abstract] [Full Text] [PDF]

				H.-B. Guo, M. Randolph, and M. Pierce Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes: INHIBITION OF EPIDERMAL GROWTH FACTOR-INDUCED DEPHOSPHORYLATION OF FOCAL ADHESION KINASE J. Biol. Chem., July 27, 2007; 282(30): 22150 - 22162. [Abstract] [Full Text] [PDF]

				J. Huang, J.-T. Liang, H.-C. Huang, T.-L. Shen, H.-Y. Chen, N.-Y. Lin, M.-I. Che, W.-C. Lin, and M.-C. Huang {beta}1,4-N-Acetylgalactosaminyltransferase III Enhances Malignant Phenotypes of Colon Cancer Cells Mol. Cancer Res., June 1, 2007; 5(6): 543 - 552. [Abstract] [Full Text] [PDF]

				M. Chiricolo, N. Malagolini, S. Bonfiglioli, and F. Dall'Olio Phenotypic changes induced by expression of {beta}-galactoside {alpha}2,6 sialyltransferase I in the human colon cancer cell line SW948 Glycobiology, February 1, 2006; 16(2): 146 - 154. [Abstract] [Full Text] [PDF]

				E. C. Seales, F. M. Shaikh, A. V. Woodard-Grice, P. Aggarwal, A. C. McBrayer, K. M. Hennessy, and S. L. Bellis A Protein Kinase C/Ras/ERK Signaling Pathway Activates Myeloid Fibronectin Receptors by Altering {beta}1 Integrin Sialylation J. Biol. Chem., November 11, 2005; 280(45): 37610 - 37615. [Abstract] [Full Text] [PDF]